Separate names with a comma.
This company will possibly acquire $ATAI, $MNMD and or $CMPS very very soon.
$ATAI$JNJ reported Q2 2025 sales of $414 million for SPRAVATO (esketamine), marking a 53% year-over-year increase—this momentum is driven by...
$ATAI J&J doesn't have to 'do deals out of desperation' despite facing patent cliffs: CFO...
$MNMD J&J doesn't have to 'do deals out of desperation' despite facing patent cliffs: CFO...
RFK Jr. and other Trump officials embrace psychedelics after FDA setback...
Sekur Private Data Ltd. (OTCQB: SWISF | CSE: SKUR) [MEDIA] Sekur (SWISF | SKUR) is a privacy-first communication platform based in Switzerland...
MAPS supporting MM-120 Trial - Poston Instagram. I would say this is big. https://www.instagram.com/p/DL-eltENqfw/?igsh=bzJscXQ4NzVyMzl1
Hope for Depression and Other Diagnoses with Psychedelics - Psychology Today...
See the pitch deck a psychedelics startup just used to raise $18.6 million to develop new treatments derived from the Sonoran Desert toad...
Massive catalysts ahead... [IMG]
It is time for a move higher in biotech, says Mizuho's Jared Holz [MEDIA]
CTIS 2025: Automated Assessment Auditing Across MindMed’s Pivotal Programs [MEDIA] Presentedy by: Dan Karlin, Chief Medical Officer, MindMed
atai Life Sciences – Strong Phase 2b topline data for BPL-003 (5-MeO-DMT) and further strategic backing atai announced very strong Phase 2b...
Strong Phase 2b results for psychedelic-based treatment BPL-003 (a nasal spray version of mebufotenin / 5-MeO-DMT) for treatment-resistant...
atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant...
Driven by a desire to help ex-servicemembers with mental illness, GOP lawmakers led a failed campaign last year to persuade the Biden...
RFK pushes the accelerator on psychedelic medicines...
High Doses Of LSD Lead To ‘Greater Reductions In Depression’ Compared To Low Doses Of The Psychedelic, New Study Finds...
